Overview

Remdesivir Efficacy In Management Of COVID-19 Patients

Status:
Completed
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
The study is open label randomized interventional phase 3 clinical trial. Patients with confirmed Covid-19 cases who was hospitalized in Two university isolation hospitals (Ain Shams University and Assiut University ) assigned hospitals for isolation.
Phase:
Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Hydroxychloroquine
Remdesivir